These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35426999)

  • 1. Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells
    Fisher L
    RSC Adv; 2021 Jan; 11(8):4439. PubMed ID: 35426999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells
    He Q; Du H; Li Y
    RSC Adv; 2019 Jan; 9(3):1717-1725. PubMed ID: 35518051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3.
    Fisher L
    RSC Adv; 2021 Jan; 11(7):4166. PubMed ID: 35427002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma [Retraction].
    Am J Transl Res; 2021; 13(11):13224. PubMed ID: 34956547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
    Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma [Retraction].
    Cancer Manag Res; 2021; 13():8061-8062. PubMed ID: 34729025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction].
    Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction].
    Onco Targets Ther; 2021; 14():5419-5420. PubMed ID: 34916805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction of "Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis".
    Liu H; Cheng J; Xu H; Wan Z
    Open Life Sci; 2022; 17(1):380. PubMed ID: 35528278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction Notice to: circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 sponge.
    Wu D; Xia A; Fan T; Li G
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102188. PubMed ID: 38665219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction.
    Wang L; Sun L; Wang Y; Yao B; Liu R; Chen T; Tu K; Liu Q; Liu Z
    Int J Biol Sci; 2022; 18(10):3942. PubMed ID: 35844782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction Note to: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.
    Fu Y; Cai L; Lei X; Wang D
    Cancer Cell Int; 2020; 20():485. PubMed ID: 33041666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction].
    Int J Nanomedicine; 2023; 18():2017-2018. PubMed ID: 37081943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.